Catalyst Pharmaceuticals Inc (CPRX) — Cash Flow Quality Index
Catalyst Pharmaceuticals Inc (CPRX) has a Cash Flow Quality Index of 0.85x as of December 2025. Operating cash flow of $44.89 Million is below net income of $52.70 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CPRX long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Catalyst Pharmaceuticals Inc Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Catalyst Pharmaceuticals Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CPRX tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Catalyst Pharmaceuticals Inc (2019–2025)
Year-by-year earnings quality comparison for Catalyst Pharmaceuticals Inc. For live market cap and the full company financial profile, see Catalyst Pharmaceuticals Inc market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.97x | $208.67 Million | $214.33 Million | ▼ -33.5% |
| 2024 | 1.46x | $239.81 Million | $163.89 Million | ▼ -27.2% |
| 2023 | 2.01x | $143.60 Million | $71.41 Million | ▲ +44.0% |
| 2022 | 1.40x | $116.05 Million | $83.08 Million | ▼ -8.7% |
| 2021 | 1.53x | $60.37 Million | $39.48 Million | ▲ +154.6% |
| 2020 | 0.60x | $45.03 Million | $74.98 Million | ▼ -44.7% |
| 2019 | 1.09x | $34.61 Million | $31.88 Million | — |